Avoid common mistakes on your manuscript.
Erratum to: Invest New Drugs
DOI 10.1007/s10637-012-9843-5
In the original version of the published article, Peter Stephens name was spelled incorrectly as Peter Stevens. The correct spelling is shown above.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at http://dx.doi.org/10.1007/s10637-012-9843-5.
Rights and permissions
About this article
Cite this article
Massard, C., Margetts, J., Amellal, N. et al. Erratum to: Phase I study of PM00104 (Zalypsis®) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors. Invest New Drugs 31, 799 (2013). https://doi.org/10.1007/s10637-013-9954-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-013-9954-7